Streamlining APSD Testing

Every lab has its rituals. For years, analysts have relied on spreadsheets, manual data entry, and fragmented tools to piece together Aerodynamic Particle Size Distribution (APSD) workflows. It worked—until it didn’t. As demands for efficiency, compliance, and traceability grew, legacy systems began to show their limits.

That’s where Inhalytix^®+ enters the story.
 

One Connected Platform

Inhalytix⁺ brings method setup, equipment configuration, test execution, and data analysis into one connected desktop or server-based environment. Instead of juggling separate files and software, analysts can now manage the entire APSD data lifecycle in a structured platform.

The real difference? Direct connectivity with compatible Copley Scientific equipment. Operational data and metadata can flow seamlessly into the system, reducing duplication and ensuring every result is captured at the source. With instruments and software linked, labs gain a unified environment where APSD testing is consistent, traceable, and future-ready.
 

Why the Shift Matters

With Inhalytix⁺, labs can move away from patchwork workflows and towards a centralized hub that ties together every stage of APSD testing.

Think of it as moving from an old filing cabinet to a modern, digital command center. The information is the same - methods, results, metadata - but now it’s automatically linked to your test equipment and structured for efficiency, compliance and audit readiness.
 

What’s New in Inhalytix⁺

Inhalytix⁺ does everything the legacy Inhalytix software could, but it also introduces new capabilities designed to simplify and strengthen APSD workflows. Supported inhaler testing instruments from Copley Scientific can connect directly to transfer operational data and metadata in real time, eliminating the need for duplicate entry. A new Equipment Bench allows analysts to build, save, and recall frequently used test configurations, reducing setup time and helping ensure consistency. Structured sign-off options bring a formal approval process into the workflow, enhancing data integrity and supporting internal quality procedures. At the same time, a centralized database links methods, results, and metadata in one place, improving visibility across the testing process.
 

Benefits That Support the Future of Testing

The benefits of this approach are clear. Workflows become more efficient by reducing manual input, while full traceability and audit trails enhance data integrity. Role-based sign-off and structured approvals support GMP and 21 CFR Part 11 requirements. Equipment usage can be monitored and managed in one environment, with all associated metadata linked to specific tests. Reporting is easier, too, with structured outputs that are ready for review or audit. Inhalytix⁺ also retains a familiar interface and database structure, helping current Inhalytix users adapt quickly while taking advantage of its enhanced capabilities.
 

A New Way of Thinking: Subscription-Based Access

Inhalytix⁺ is available through a three-year subscription, ensuring ongoing access to the latest version, continuous feature updates, and technical support, all within a predictable cost structure and without the need for unexpected upgrade fees.
 

The Takeaway

Legacy Inhalytix served its purpose well, but APSD workflows grow in complexity. Inhalytix⁺ takes the next step by connecting compatible Copley equipment directly into the data management process. This integration means no more patchwork of tools, but just one environment where methods, results, and equipment data are unified, structured, and ready for the future of inhaler testing.

 

Learn more about Inhalytix⁺

 

Inhalytix® is a registered trademark of Copley Scientific.